CAR-T 细胞治疗胰腺癌的进展、挑战与创新策略
Advances, challenges, and innovative strategies of CAR-T cell therapy in pancreatic cancer.
胰腺癌仍然是全球最致命的恶性肿瘤之一,其中胰腺导管腺癌(PDAC)占大多数病例,且预后持续不佳。
93.6分
★★★★★
ALL SOURCES
Advances, challenges, and innovative strategies of CAR-T cell therapy in pancreatic cancer.
胰腺癌仍然是全球最致命的恶性肿瘤之一,其中胰腺导管腺癌(PDAC)占大多数病例,且预后持续不佳。
Challenges and recent advances in CAR-T cell therapy for solid tumors.
CAR-T 细胞疗法在血液系统恶性肿瘤中取得了革命性成功。
Immunotherapy in Gastrointestinal Cancers: Current Insights.
例如,过继性T细胞疗法,如靶向claudin18.2的CAR-T,在晚期胃癌和胃食管结合部癌患者中已达到48.6%的客观缓解率。
共 3 条
MEMBER ACCOUNT
登录成功会直接打开下一页。